UK pharma downbeat on its future – survey
November 8, 2011Research and Development ABPI, R&D, VBP, rsa
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
Organising a successful event
November 8, 2011Sales and Marketing
Company conferences and events have come a long way since we used to be taken out for a short meeting …
Market access – looking back
November 8, 2011Sales and Marketing
Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …
Daniel Grau appointed as president of Heptares
November 8, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Grau, Heptares
Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors. Mr Grau has been a …
Pfizer to retain an extra 300 jobs at Sandwich site
November 8, 2011Manufacturing and Production, Research and Development Jobs, Pfizer, Sandwich
Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
TranslatePharma now partnered with European Regulatory Solutions
November 8, 2011As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …
GSK taps Alnylam tech for vaccine production
November 7, 2011Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines
GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …
Bosch planning second packaging plant in China
November 7, 2011Manufacturing and Production Bosch, China
Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …
Contract research news in brief
November 7, 2011Manufacturing and Production
No new suitors come forward for PPD, Icon and Charles River report mixed Q3 results, plus updates from Cyprotex and …
Ex-Pfizer R&D head Dr David Roblin joins Destiny Pharma
November 7, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Destiny Pharma, Pfizer, R&D
Anti-microbial drug developers Destiny Pharma have appointed Dr David Roblin as its new medical director. Dr Roblin was formerly head …
Aslan licences promising cancer drug from Bristol-Myers Squibb
November 7, 2011Research and Development, Sales and Marketing Aslan, BMS, Cancer
Bristol-Myers Squibb has licensed one of its investigational oncology compounds, for the treatment of multiple solid tumours, to Singapore-based Aslan …
Xarelto gains lucrative new licence from FDA
November 7, 2011Sales and Marketing
The FDA has approved Bayer/J&J’s Xarelto once-daily pill for stroke prevention in patients with an abnormal heart rhythm. The US …
Ranbaxy to collaborate with Teva on generic Lipitor in US?
November 7, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Israeli drugmaker Teva Pharmaceutical could get an unexpected boost from an earlier-than-expected launch of its generic version of Pfizer’s cholesterol …
Steve Hobbs joins Apodi senior management team
November 4, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Steve Hobbs has joined Apodi’s senior management team as director of business and account development. Steve has over 30 years …
Graham Higson joins NDA Group to lead Regulatory and HTA Advisory Board
November 4, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA
GE Healthcare and ex AstraZeneca Head of Global Regulatory Affairs, Graham Higson, will join NDA Group in January 2012 to …
FDA boasts better approval rates than Europe
November 4, 2011Medical Communications, Research and Development FDA, approvals
US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …
GSK, Pfizer joint venture to start manufacturing ops in Russia
November 4, 2011Manufacturing and Production GSK, Pfizer, manufacturing
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
Ketchum wins International Consultancy of the Year award
November 3, 2011Medical Communications Ketchum, Ketchum Pleon, PR
Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …
GSK pays $3 billion to settle US marketing probe
November 3, 2011Sales and Marketing GSK, compliance, federal investigation
GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
